Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on the current treatment paradigm for Atopic Dermatitis, the role of PDE4 in AD, and the mechanism of action Crisaborole.
The current treatment paradigm for Atopic Dermatitis (AD) emphasizes a multifaceted approach targeting inflammation and itch relief. Topical corticosteroids and calcineurin inhibitors are frontline treatments, while systemic therapies may be considered for severe cases. Additionally, emerging biologic agents targeting specific immune pathways offer promising options for refractory AD.
Phosphodiesterase-4 (PDE4) inhibitors, like Crisaborole, have gained attention for their role in AD management. PDE4 regulates inflammatory responses by degrading cyclic adenosine monophosphate (cAMP), thereby modulating cytokine production. In AD, elevated levels of pro-inflammatory cytokines contribute to skin inflammation and barrier dysfunction. By inhibiting PDE4, Crisaborole reduces inflammation and restores skin barrier function, offering a targeted approach to AD treatment with favorable safety and efficacy profiles.
Therefore, get an overall knowledge of the current treatment paradigm for Atopic Dermatitis, the role of PDE4 in AD, and the mechanism of action Crisaborole. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
2.
More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.
3.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
4.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
5.
Squeezing through tiny blood vessels may trigger melanoma cells to spread
1.
The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies
2.
Everything You Need to Know About Leiomyomas: A Comprehensive Guide
3.
The Importance of Corrected Calcium Levels in Managing Health Conditions
4.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
5.
Cowden Syndrome and Cancer: Understanding the Risk Factors
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation